α-SMA/VCAM-1 Dual-Targeted Nanoplatform Improves Drug Release and Therapeutic Efficacy in Liver Fibrosis
Withdrawal StatementThis article has been withdrawn by bioRxiv because it was submitted with false information
bioengineering↗
Biology subjects
Bennett, O. J.
Publications and source records attributed to Bennett, O. J..